. Other are components of the SRB complex, also known as experiments have shown that recruiting a component the mediator, which is tightly associated with the RNA of the SRB complex to promoters, presumably in associpolymerase II C-terminal repeat domain. The SWI/SNF ation with the holoenzyme, suffices to obtain activated levels of transcription in vivo (Barberis et al., 1995) .
First, genetic evidence suggests a functional relationship between the SWI and SNF gene products and the CTD. Strains containing mutations in SWI genes exhibit a large number of defects similar to those due to a truncation of the RNA polymerase II CTD (Nonet et al., 1987; Peterson and Herskowitz, 1992; Peterson et al., 1991) . In addition, the CTD and the SWI/SNF gene products show similar genetic interactions with mutations in SIN1 and SIN2, genes that encode chromatin-associated proteins Peterson et al., 1991) . Second, the SRB gene products have functional and physical interactions with the RNA polymerase II CTD , which has been implicated in the response to activators in yeast and mammalian cells (Allison and Ingles, 1989; Gerber et al., 1995; Scafe et al., 1990) . Third, the holoenzyme appears to be responsible for initiating transcription of most, if not all, class II genes in yeast, and the SWI and SNF of a large number of genes in vivo (Thompson and Immunoprecipitations were from a crude DEAE fraction prepared Peterson et al., 1991) . Finally, there are as described by Hengartner et al. (1995) . Immunoprecipitations were perhaps a dozen polypeptides in purified yeast RNA carried out with affinity-purified antibodies against SWI3, SRB5, or polymerase holoenzyme that have yet to be identified.
TGF␤. Ovalbumin and HA-tagged GST were added to each reaction prior to precipitation to serve as controls for specific immunoprecipiWe report here that the yeast RNA polymerase II holotation; 1/50 of the onput and flowthrough, and 1/5 of the final wash enzyme contains SWI2/SNF2, SWI3, SNF5, and SNF11. and eluate were subjected to SDS-PAGE and analyzed by Western
The SWI/SNF proteins are components of the SRB blotting using specific antibodies.
complex, also known as the mediator, which is tightly associated with the RNA polymerase II CTD. Both the SRB and SWI/SNF proteins are tightly associated with holoenzyme and the SRB/SWI/SNF complex have ATPone another. dependent nucleosome disruption activities previously ascribed to the SWI/SNF complex. In addition, the holoPurified Holoenzyme Contains enzyme facilitates the binding of TATA box-binding pro-SWI/SNF Proteins tein (TBP) to nucleosomal DNA in an ATP-enhanced
The immunoprecipitation results led us to investigate manner.
whether SWI and SNF proteins are components of purified yeast RNA polymerase II holoenzyme. Antibodies against selected SWI and SNF proteins were used to Results determine whether these proteins coelute with the RNA polymerase II holoenzyme in the final purification step Anti-SRB and Anti-SWI Antibodies of the holoenzyme. The data in Figure 2A demonstrate Coprecipitate Holoenzyme that SNF2/SWI2, SNF5, SWI3, and SNF11 proteins coe-SRB regulatory proteins are found tightly and exclulute with other known components of the holoenzyme sively associated with other components of the RNA and with transcription activity. polymerase II holoenzyme in cell extracts. If SWI and
The holoenzyme contains stoichiometric amounts of SNF proteins are subunits of the RNA polymerase II RNA polymerase II, SRB proteins, and general transcripholoenzyme, then antibodies against SRB5 should tion factors. To ascertain whether the SWI/SNF proteins precipitate both the holoenzyme and SWI/SNF proare stoichiometric components of the holoenzyme, the teins from crude extracts. The results in Figure 1 show amounts of SNF2 and SNF5 were estimated by Western that this is indeed the case. SWI2/SNF2, SWI3, and blot analysis with various amounts of recombinant pro-SNF5 proteins coprecipitate with holoenzyme obtained teins as standards ( Figure 2B ). These data indicate that through SRB5 immunoprecipitation. The fraction of SWI the purified RNA polymerase II holoenzyme contains and SNF proteins immunoprecipitated from the crude approximately equimolar amounts of SNF2, SNF5, and extract appears to be the same as that of the SRB pro-SRB5, the latter being a standard against which other teins. Control proteins introduced into the crude lysate holoenzyme components have previously been comdid not coprecipitate, indicating that the immunoprecipipared . Since yeast cells contate was specific for the holoenzyme. When the immunotain between 2000 and 4000 molecules of RNA polymerprecipitation experiment was carried out with antibody ase II holoenzyme, it appears that there are at least this against SWI3, essentially identical results were obtained number of SWI2/SNF2 and SNF5 molecules per cell. (Figure 1 ). The SWI/SNF and SRB proteins were immunoprecipitated from the crude extract with similar effi-SWI/SNF Proteins Are Components of ciency whether the immunoprecipitating antibody used CTD-Binding SRB Complexes was directed against SRB5 or SWI3. A control experiGenetic evidence indicates that the SRB regulatory proment with antibody against TGF␤ failed to precipitate teins and the RNA polymerase II CTD have related functions in transcription initiation and that these involve SWI/SNF or SRB proteins. These results indicate that Mediator was Western blotted along with holoenzyme and core polymerase and probed for the presence of SWI/SNF proteins. The mediator preparation was previously assayed (Hengartner et. al., 1995) and shown to have all transcriptional activities previously described . son et al., 1993 ). An SRB complex was purified extensively by using a recombinant glutathione S-transferase (GST)-CTD column, followed by chromatography with Mono S and Mono Q columns ( Figure 4A ). The SRB, SWI, and SNF proteins bind to a GST-CTD column, but not to a control GST column, indicating that they bind specifically to the CTD ( Figure 4B ). Sliver staining and Western blotting confirm that both a multiprotein complex containing SRB proteins and each of the three as- (A) RNA polymerase II holoenzyme eluted from a Mono S column, the last chromatographic step in the purification procedure , was analyzed for transcriptional activity and for the presence of SRB and SWI/SNF proteins by Western blotting. (B) Quantitative Western blots were used to determine the relative amounts of SRB5 and SWI/SNF proteins in the holoenzyme. Known amounts of recombinant GST-SNF2/SWI21256-1703, GST-SNF51-193, and SRB5 were subject to SDS-PAGE and Western blot analysis along with 2.5 l and 0.5 l of purified holoenzyme. There are similar levels of SNF2/SWI2, SNF5, and SRB5 in the purified holoenzyme Previous studies have shown that RPB1 and other SRB proteins are equimolar in purified holoenzyme . the response to transcriptional regulators (Allison and Ingles, 1989; Gerber et al., 1995; Scafe et al., 1990; . Since the SWI and SNF proteins are also involved in activation of a wide variety of genes and since mutations in SWI and SNF genes can produce phenotypes similar to those observed with mutations in SRB genes, we investigated whether SWI and SNF proteins are associated with the SRB complex. The SRB protein complex can be released from the holoenzyme when the latter is treated with monoclonal antibodies against the CTD, and this preparation has been called mediator . We previously prepared a mediator complex according to the procedure of , confirmed that it has the coacti- (Hengartner et al., 1995) . When this mediator prepcolumn. Western blot analysis of proteins eluted from a GST column aration was assayed for the presence of SNF2/SWI2, and from a GST-CTD column. TFIIE was a negative control for SNF5, and SWI3 proteins by Western blot, all three SWI/ specific retention, as it does not bind GST or GST-CTD. extracts using a recombinant CTD column (Thomp- umn ( Figures 4C and 4D ). There are approximately 25 SWI/SNF complex showed that the nucleosome disruppolypeptides in this complex, and several correspond in tion activity was ATP dependent (Figures 6B and 6D) , as size to previously identified SRB, SWI, and SNF proteins was previously shown for purified SWI/SNF complexes ( Figure 5 ). No signals were obtained when Western blots (Cô té et al., 1994; Imbalzano et al., 1994 ; Kwon et al., containing the SRB/SWI/SNF complex were probed with 1994). In addition, purified core RNA polymerase II antibodies against RNA polymerase II, TBP, TFIIB, or the showed no nucleosome alteration capability (data not TFB1 subunit of TFIIH (data not shown). These results shown). These data indicate that the SRB/SWI/SNF indicate that the SRB complex is in fact an SRB/SWI/ complex contributes chromatin remodeling activity to SNF complex and, furthermore, that the SWI and SNF the RNA polymerase II holoenzyme. proteins interact with the holoenzyme, at least in part through their association with RNA polymerase II CTD.
Purified Holoenzyme and the SRB/SWI/SNF Complex Disrupts Plasmid Chromatin Nucleosome Disruption Activity in Holoenzyme
To characterize further the nucleosome disruption capaand SRB/SWI/SNF Complex bilities of the holoenzyme and the SRB/SWI/SNF comPrevious evidence that SWI1, SWI2, SWI3, SNF5, SNF6, plex, we employed a supercoiling reduction assay (Figand SNF11 gene products can be isolated as a large ure 7). In this assay, chromatin is assembled onto a multisubunit complex capable of altering nucleosome relaxed closed-circular plasmid that is subsequently pustructure led us to investigate whether the purified RNA rified by glycerol gradient centrifugation. Each assempolymerase II holoenzyme and the SRB/SWI/SNF combled nucleosome introduces approximately one negaplex were able to alter nucleosome structure. Monotive supercoil to the plasmid, which can be resolved by nucleosome particles were reconstituted from purified agarose gel electrophoresis after the removal of hishistone octamers and a DNA fragment containing two tones. When no protein is added to the nucleosomecopies of an artificial phasing sequence (Shrader and assembled plasmid, it is highly supercoiled. Fractions Crothers, 1989). Digestion of the mononucleosomes from the last column of the holoenzyme purification (see with DNase I showed a 10 bp cleavage ladder typical of Figure 2A ) were tested for their ability to disrupt nucleoa rotationally phased nucleosome ( Figure 6 ). Fractions in some structure and thereby reduce supercoiling in the the last chromatographic step in the purification of the presence of added topoisomerase I. As can be seen in holoenzyme were mixed with mononucleosomes and Figure 7A , this activity coelutes with holoenzyme tranassayed for the ability to alter nucleosome structure, scription activity, with the SRB and SWI/SNF proteins which can be visualized by changes in the accessibility (see Figure 2A) , and with nucleosome-core disruption of the nucleosome to DNase I cleavage. Figure 6A demactivity (see Figure 6A ). The supercoiling reduction activonstrates that a nucleosome disruption activity coeluted ity was dependent on ATP ( Figure 7A , compare fraction with the RNA polymerase holoenzyme. The ability of the 61 plus and minus ATP), as has been shown for the SRB/SWI/SNF complex to alter nucleosome structure human SWI/SNF complex . Repeating was assayed in a similar experiment using fractions from the experiment using fractions from the last column of the last step in the SRB/SWI/SNF purification (Figure the SRB/SWI/SNF complex shows that this complex 6C). The results show that nucleosome disruption activalso has an ATP-dependent supercoiling reduction acity coeluted with the SRB/SWI/SNF complex. Further analysis of the RNA polymerase II holoenzyme and SRB/ tivity ( Figure 7B ).
Holoenzyme Facilitates the Binding of TBP to Nucleosomes
Previous work has shown that both yeast and human SWI/SNF complexes can facilitate transcription factor binding to nucleosomal DNA containing the relevant factor-binding site (Cô té et al, 1994; Imbalzano et al, 1994; . We tested whether the holoenzyme could increase the binding of TBP to a mononucleosome containing a TBP-binding site. With holoenzyme and ATP present, TBP and TFIIA bound to the mononucleosome at TBP concentrations of 4 ϫ 10 Ϫ6 M ( Figure 8A , lane 7), while no TBP/TFIIA binding was observed in the absence of holoenzyme ( Figure 8A, lane 6) .
This holoenzyme-facilitated TBP binding might be caused by the stabilizing effects of the additional protein-protein and protein-DNA interactions that occur in the presence of RNA polymerase and general transcription factors, by the ATP dependent nucleosome disruption effects of SWI/SNF, or by a combination of both effects. To address this issue, we tested whether facilitated TBP binding was ATP dependent and observed partial protection of the TATA region on the mononucleosome when ATP is withheld or when ATP␥S is used instead of ATP ( Figure 8B , lanes 4 and 6). However, addition of ATP enhanced the TBP binding as indicated by the increased protection from DNase I cleavage over the TATA box, the extension of the footprint in the 5Ј direction, and the appearance of a hypersensitive band in the 3Ј direction ( Figure 8B , lane 5). Thus, it appears that the holoenzyme can partially stabilize binding of TBP and TFIIA to a mononucleosome in the absence of ATP. However, the full effect of holoenzyme-facilitated TBP binding requires ATP, presumably because it involves the ATP-dependent nucleosome disruption activity of the SWI/SNF proteins.
Discussion
The RNA polymerase II holoenzyme contains SWI and SNF gene products, previously identified as global gene coactivators. The SWI and SNF proteins are components of an SRB/SWI/SNF complex, also known as the mediator, which is tightly associated with the RNA polymerase II CTD. Both the holoenzyme and the SRB/SWI/ SNF complex have nucleosome disruption activities previously ascribed to the SWI/SNF complex. In addition, the holoenzyme facilitates the binding of TBP to nucleosomal DNA in an ATP-enhanced manner.
Diverse Transcriptional Activators Require SWI/SNF Function In Vivo
Mutations in SWI1, SWI2/SNF2, SWI3, SNF5, and SNF6 cause a substantial reduction in the ability to activate transcription of a wide variety of well-studied genes (Stern et al., 1984) , SUC2 lutes with the Holoenzyme and the SRB/SWI/SNF Complex (Neigeborn and Carlson, 1984) , Ty (Happel et al., 1991) , (A) Fractions from the last column of holoenzyme purification ( Figure  2A ) were assayed for nucleosomal disruption. The peak of nucleosomal disruption activity is in fractions 59-63, coincident with the peak of transcriptional activity. (B) Purified RNA polymerase II holoenzyme (fraction 60) was titrated peak of nucleosomal disruption activity is in fractions 23 and 24, for activity with and without 4 mM ATP, as indicated.
which is also where the bulk of SRB and SWI/SNF proteins elute. INO1 , and ADH1 and ADH2 (Pe- . Ptashne and colleagues have shown that recruiting a component of the SRB terson and Herskowitz, 1992; Taguchi and Young, 1987) .
complex to promoters, presumably in association with For example, ADH1 and SUC2 gene expression is rethe holoenzyme, suffices to obtain activated levels of duced by about an order of magnitude in strains in which transcription in vivo (Barberis et al., 1995 ; M. Ptashne, SWI1, SWI2, or SWI3 has been deleted (Peterson and personal communication) . Thus, evidence that LexA fuHerskowitz, 1992). Experiments with reporter constructs sions with SWI2/SNF2, SNF5, SNF6, and SNF11 proteins have revealed that the SWI and SNF gene products are sufficient to activate transcription of a target gene are required for normal responses to a variety of genein vivo (Laurent et al., 1990 (Laurent et al., , 1991 Treich et al., 1995 ) specific activators in yeast such as GAL4, Drosophila might now be interpreted in terms of holoenzyme recruitfushi tarazu, mammalian glucocorticoid and estrogen ment to the target promoter. receptors, and LexA-GAL4 and LexA-Bicoid fusion proWe propose that recruitment of the holoenzyme to a teins Laurent and Carl- specific promoter in vivo provides a means to facilitate son, 1992; Yoshinaga et al., 1992) .
TBP binding, regardless of the nucleosome structure at We have proposed that the RNA polymerase II holoenthat promoter. The holoenzyme can enhance binding of zyme is recruited to promoters by activators in vivo TBP and TFIIA to a mononucleosome in vitro in the absence of ATP (Figure 8 ), a result compatible with evidence that the polymerase and general transcription factor components of the holoenzyme provide additional protein-protein and protein-DNA interactions that should stabilize TBP binding (Buratowski, 1994) . Holoenzyme-facilitated TBP binding to a mononucleosome is greater in the presence of ATP, which presumably reflects the ATP-dependent nucleosome disruption activity of the SWI/SNF proteins. These observations are consistent with the idea that SWI/SNF protein function is necessary at the subset of promoters whose chromatin structure is particularly restrictive for TBP binding.
SWI/SNF in the Holoenzyme Accounts for Previous Genetic Observations
The presence of SWI/SNF proteins in the RNA polymerase II holoenzyme and the observation that these proteins are components of a subcomplex that interacts with the RNA polymerase II CTD explain several previous observations. SWI/SNF proteins are necessary for transcription activation of many genes in yeast cells (reviewed by Winston and Carlson, 1992; Carlson and yeast and mammalian cells (Allison and Ingles, 1989;  ATP were tested for the ability to bind to a TATA box containing Scafe et al., 1990; Gerber et al., 1995) . Cells with RNA nucleosome with and without holoenzyme present.
polymerase II CTD truncation mutations, cells with cer-(B) Nucleosomes were incubated with and without holoenzyme, 4 mM ATP or 4 mM ATP␥S, yTBP and yTFIIA, as indicated.
tain SRB mutations, and cells with SWI1, SWI2, or SWI3 mutations exhibit remarkably similar phenotypes (PeWestern blot analysis did not reveal the presence of SRB proteins Cairns et al., 1994) . terson and Herskowitz, 1992; Thompson et al., 1993; Hengartner et al., 1995) . The association of the SRB/ This suggests that the purification procedures employed in these studies separated the SRB and SWI/SNF pro-SWI/SNF complex with the CTD accounts for the observation that cellular defects due to CTD mutations and teins or that SWI/SNF complexes can exist independent of the holoenzyme. SWI mutations can be alleviated by mutations in SIN1 and SIN2, which encode an HMG1-related protein and Since SWI2/SNF2 and SNF5 are stoichiometric components of the holoenzyme and since yeast cells contain histone H3, respectively Peterson et al., 1991; Peterson and Herskowitz, 1992 Koleske et al., 1996; Hengartner et al., into holoenzyme or, alternatively, it represents a sub-1995; Liao et al., 1995;  reviewed by Koleske and Young, complex that can be dissociated from the holoenzyme. 1995). Only very small amounts of SRB protein can be The ability to immunoprecipitate very similar holoendetected that are not associated with the holoenzyme.
zyme complexes from crude yeast fractions using antiTwo different methods have been described that permit SRB and anti-SWI antibodies suggests that most of the partial purification of an SRB subcomplex. An SRB com-SWI/SNF protein in these fractions is associated with plex can be isolated using a CTD affinity column the holoenzyme. If the SRB and SWI/SNF proteins were (Thompson et al., 1993) or by releasing it from a holoenin separate complexes, then the relative ratios of SRB zyme preparation by using monoclonal anti-CTD antiand SWI/SNF proteins would differ in the anti-SRB and bodies . Because neither of these prepanti-SWI immunoprecipitates. However, the similar relaarations is homogeneous, we further purified the SRB tive ratios of SRB and SWI/SNF proteins found in immucomplex obtained by CTD affinity chromatography (Fig- noprecipitates obtained with anti-SRB and anti-SWI anure 4). The SRB and SWI/SNF proteins coelute in the tibodies (Figure 1 ) indicate that the SRB and SWI/SNF final step of the purification.
proteins are components of the same complex in the We also found that the SRB complex isolated by anticrude extract. CTD antibody release contains SWI and SNF proteins. demonstrated that reconstitution of the SWI/SNF Function Is Highly Conserved response of the holoenzyme to activators required the in Eukaryotes presence of a subcomplex that could be isolated from SWI/SNF proteins and their functions appear to be holoenzyme with anti-CTD antibodies, which contained highly conserved in eukaryotes. Putative homologs of SRB2, SRB4, SRB5, and SRB6, and was called the medi-SNF2/SWI2 include Drosophila brahma and human ator of activation. Our own studies with the mediator, hbrm and hBRG1, which have been cloned and impliwhich was purified precisely as described by Kim et cated in transcriptional regulation (Tamkun et al., 1992; and has chromatographic and transcriptional Khavari et al., 1993; Muchardt and Yaniv, 1993) . A mamproperties identical to those originally described for this malian homolog of SNF5, called INI1, has also been subcomplex, revealed that it contained all nine of the cloned (Kalpana et al., 1994) . A human SWI/SNF comknown SRB proteins (Hengartner et al., 1995) . Thus, the plex has been partially purified that has nucleosome mediator preparation and the SRB complex obtained by disruption activities similar to those of the yeast SWI/ CTD affinity chromatography contain very similar, if not SNF complex . identical, complexes.
The human SWI/SNF complex contains both hBRG1 and We have shown that the RNA polymerase II holoen-INI1 proteins (Kalpana et al., 1994 ; G. R. S., unpublished zyme, and its SRB/SWI/SNF subcomplex, contain SWI2/ data), as would be expected based on the yeast results. SNF2, SWI3, SNF5, and SNF11. Although we do not Like the yeast SWI/SNF complex, the human SWI/SNF have direct biochemical evidence that SWI1 and SNF6 complex facilitates the binding of activators to nucleoare present in the holoenzyme, other genetic and biosomal DNA. chemical data indicate that it is highly likely that SWI1 and SNF6 are also subunits of these complexes (Cairns et al., 1994; Cô té et al., 1994; Laurent and Carlson, 1992;  Implications for Mechanisms Involved Laurent et al., 1991; Peterson and Herskowitz, 1992 an activator for a specific DNA site could be resolved g of protein) were thawed and pooled; 320 ml of buffer A plus 2% in favor of the activator once the SWI/SNF-containing Triton X-100 were added, and the mixture was centrifuged for 30 holoenzyme was recruited to the promoter. In this min at 12,000 rpm in a GSA rotor (Sorvall). The supernatant was loaded onto a 15 ml CTD affinity column prepared as described model, the activator and the holoenzyme both contribute (Thompson et al., 1993) at a flow rate of 200 ml/hr. The column was to stable transcription initiation complex formation; the washed with 100 ml of buffer A plus 300 mM KOAc plus 1% Triton activator recruits the holoenzyme by binding to a subset X-100, or 100 ml of buffer A plus 300 mM KOAc. Bound proteins of its components, and the SWI/SNF components of the were eluted with buffer A plus 300 mM KOAc plus 1 M urea at a holoenzyme enhance the stability of the activator-DNA flow rate of 25 ml/hr. Fractions containing protein (3.7 mg) were interaction by destabilizing nucleosomes. This model is pooled, frozen in liquid nitrogen, and stored at Ϫ70ЊC. The CTD column was equilibrated with buffer A plus 300 mM KOAc plus 1%
attractive because it provides a simple solution to the Triton X-100, and the flowthrough was loaded again. The column question of how SWI/SNF proteins are brought to prowas washed and eluted as before. Fractions containing protein (1.8 moters and it accounts for the coactivating and nucleomg) were pooled, frozen in liquid nitrogen, and stored at Ϫ70ЊC.
some disruption activities observed in vivo and in vitro
The CTD eluates were pooled, diluted with 1.5 vol of buffer A plus for the SWI and SNF proteins.
0.01% NP-40, and centrifuged for 10 min at 17,000 rpm in an SS-34 rotor (Sorvall). The supernatant was loaded onto a Mono S HR Experimental Procedures 5/5 (Pharmacia) at a flow rate of 0.3 ml/min. The column was washed with 3 ml of buffer A plus 120 mM KOAc plus 0.01% NP-40. Bound proteins were eluted with a 20 ml gradient of buffer A plus 0.01% Immunoprecipitations NP-40 from 120 mM to 1000 mM KOAc. Fractions were frozen in All immunoprecipitations were done as described (Hengartner et liquid nitrogen and stored at Ϫ70ЊC until use. Fractions containing al., 1995) . In brief, 50 l of the DEAE 400 fraction was diluted 1:4 SRB4 and SRB5 as assayed by Western blotting were pooled and with modified transcription buffer (MTB) (50 mM HEPES-KOH [pH diluted with 2 vol of buffer B (20 mM Tris OAc [pH 7.6] plus 20% 7.3], 100 mM potassium acetate, 25 mM MgAc, 5 mM EGTA, 1 M glycerol plus 1 mM DTT plus 0.01% NP-40 plus protease inhibitors). DTT, 10% glycerol, 0.01% NP-40, 1 mM PMSF, 2 mM benzamidine,
The mixture was centrifuged for 5 min in a microcentrifuge. The 2 M pepstatin A, 0.6 M leupeptin, and 2 g/ml chymostatin) minus supernatant was loaded onto a Mono Q HRR 5/5 column (Pharmacia) the postassium acetate. We added 4 g of ovalbumin, 4 g HAat a flow rate of 0.3 ml/min. The column was washed with 1 ml of GST, and 2 g of BSA to each reaction prior to the addition of buffer B plus 200 mM KOAc. Bound proteins were eluted with a 40 antibody and then added 0.4 g of affinity-purified ␣-SRB5, 0.15 ml gradient of buffer B from 200 mM to 2000 mM KOAc. The yield g of affinity-purified ␣-SWI3, or 1.5 g of affinity-purified ␣-TGF␤ of SRB complex was approximately 100 g. We analyzed 1 l of to the respective reactions and allowed them to incubate 2 hr at each fraction by silver staining and 7.5-10 l of each fraction by 4ЊC; 15 l of goat anti-rabbit covalently linked to magnetic beads Western blotting. (Dynal) were then added and incubated for 1 hr at 4ЊC with constant agitation. Beads were precipitated with a magnet and washed three times in 200 l of MTB buffer. The final wash contained no NP-40.
Nucleosomal Disruption and Facilitated Proteins were eluted off the magnetic beads by boiling in 20 l of Transcription Factor Binding Assays sample buffer.
The PH MLT (Figure 6 ) or PH MLT(ϩ3) (Figure 8 ) restriction fragments were assembled into rotationally phased mononucleosome partiWestern Blotting cles, purified by glycerol gradient centrifugation, and assayed as All Western blots were performed as described (Koleske and Young, described (Imbalzano et al., 1994) . At the nucleosome concentra-1994). Proteins were detected with the following antibodies: SRB2, tions and reaction conditions employed in this and previous studies, SRB4, SRB5, SRB6 (Thompson et al., 1993) , SRB8, SRB9 (Hengartnucleosomes were determined to be stable on the basis of resisner et al., 1995), SRB10, SRB11 , SWI2/SNF2, SNF5 tance to micrococcal nuclease, the appearance of a 10 bp repeat (gift of B. Laurent), SWI3 (gift of C. Peterson), SNF11 (gift of I. Treich pattern upon DNase I digestion, and exhibition of reduced mobility and M. Carlson), TFIIE␣, and TFIIE␤ (C. J. W. and R. A. Y., unpubupon electrophoresis in native polyacrylamide gels. We have not lished data). Quantitative Western blots were performed as deobserved the appearance of free DNA due to nucleosome dissociascribed . Recombinant standards were tion in any of our experiments. SRB5 , GST-SNF2/SWI21256-1703, and
In Figure 6 , holoenzyme fractions were the same as those used GST-SNF5 (gifts of B. Laurent). GST proteins were purified as in Figure 1A . In Figure 6A , 0.3 l of each fraction was assayed in described (Smith and Johnson, 1988) . Concentrations of recombithe presence of 4 mM ATP. For the titration of holoenzyme, 0 l, nant proteins were determined using a colorimetric assay (Bio-Rad) 0.015 l, 0.05 l, 0.15 l, and 0.5 l of fraction 60 was used, respecwith bovine serum albumin as a standard.
tively, with and without 4 mM ATP as indicated. SRB/SWI/SNF fractions were the same as those used in Figures 3C and 3D . In Figure  Purification of Holoenzyme and Mediator 6C, 1.7 l of each fraction was assayed in the presence of 4 mM Holoenzyme was purified as described .
ATP. For the titration in Figure 6D , 0 l, 0.07 l, 0.2 l, 0.7 l, and Transcription assays for holoenzyme were done as described 2.0 l of fraction 24 was used, respectively, with and without 4 mM . Mediator was purified as described ATP as indicated. (Hengartner et al., 1995) .
For Figure 8 , binding of yeast TBP (yTBP) and yTFIIA to nucleosomes containing the PH MLT(ϩ3) restriction fragment was performed as previously described . In Figure  SRB /SWI/SNF Complex Purification Whole-cell extract was prepared from Red Star yeast as described 8A, all reactions contained 4 mM ATP. Following a 30 min incubation at 30ЊC in the presence or absence of holoenzyme (as indicated), (Thompson et al., 1993) . We centrifuged 1.2 liters of the ammonium sulfate pellet for 30 min at 5,000 rpm in an RC3B centrifuge (Sorvall).
increasing amounts of yTBP in the presence of yTFIIA were added. TBP concentrations were 0 (lanes 1, 3, and 10), 0.04 M (lanes 2, The pellet was resuspended in 900 ml of buffer A (20 mM K-HEPES [pH 7.6], 1 mM EDTA, 1 mM DTT, 20% glycerol, and protease inhibi-4, and 9), 0.4 M (lanes 5 and 8), and 4 M (lanes 6, 7). yTFIIA (1.5 M) was also added to all reactions. In Figure 8B , reactions were tors [Thompson et al., 1993] ). The suspension was centrifuged again for 30 min at 5,000 rpm in an RC3B centrifuge (Sorvall). The supernatreated with holoenzyme, alone (lanes 2 and 4), in the presence of 4 mM ATP (lanes 3 and 5), or in the presence of 4 mM ATP␥S (lane tant was mixed with 200 g (dry) of BioRex 70 and stirred for 20 min. The suspension was packed into a column with a 5 cm diameter 6) for 30 min at 30ЊC, followed by addition of 4 M yTBP in the presence of 1.5 M yTFIIA. and washed with 1.5 liters of buffer A plus 100 mM KOAc. Bound
